Credit Agricole’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $27M | Sell |
55,672
-41,043
| -42% | -$19.9M | 0.08% | 156 |
|
2024
Q4 | $38.9M | Sell |
96,715
-1,792
| -2% | -$722K | 0.11% | 115 |
|
2024
Q3 | $45.8M | Buy |
98,507
+18,555
| +23% | +$8.63M | 0.2% | 73 |
|
2024
Q2 | $37.5M | Buy |
79,952
+31,359
| +65% | +$14.7M | 0.2% | 82 |
|
2024
Q1 | $19.1M | Buy |
48,593
+16,663
| +52% | +$6.56M | 0.21% | 50 |
|
2023
Q4 | $13M | Buy |
31,930
+17,899
| +128% | +$7.28M | 0.15% | 68 |
|
2023
Q3 | $4.88M | Sell |
14,031
-10,127
| -42% | -$3.52M | 0.08% | 126 |
|
2023
Q2 | $8.5M | Sell |
24,158
-572
| -2% | -$201K | 0.15% | 67 |
|
2023
Q1 | $7.79M | Sell |
24,730
-2,045
| -8% | -$644K | 0.16% | 68 |
|
2022
Q4 | $7.73M | Buy |
26,775
+13,618
| +104% | +$3.93M | 0.16% | 68 |
|
2022
Q3 | $3.81M | Buy |
13,157
+10,763
| +450% | +$3.12M | 0.07% | 116 |
|
2022
Q2 | $675K | Buy |
2,394
+1,698
| +244% | +$479K | 0.02% | 249 |
|
2022
Q1 | $181K | Sell |
696
-50
| -7% | -$13K | ﹤0.01% | 354 |
|
2021
Q4 | $164K | Hold |
746
| – | – | ﹤0.01% | 357 |
|
2021
Q3 | $135K | Sell |
746
-2,895
| -80% | -$524K | ﹤0.01% | 346 |
|
2021
Q2 | $734K | Buy |
3,641
+2,891
| +385% | +$583K | 0.02% | 225 |
|
2021
Q1 | $161K | Sell |
750
-11,430
| -94% | -$2.45M | ﹤0.01% | 310 |
|
2020
Q4 | $2.88M | Buy |
12,180
+12,046
| +8,990% | +$2.85M | 0.09% | 124 |
|
2020
Q3 | $36K | Buy |
134
+34
| +34% | +$9.13K | ﹤0.01% | 347 |
|
2020
Q2 | $29K | Sell |
100
-100
| -50% | -$29K | ﹤0.01% | 323 |
|
2020
Q1 | $48K | Hold |
200
| – | – | ﹤0.01% | 294 |
|
2019
Q4 | $44K | Hold |
200
| – | – | ﹤0.01% | 309 |
|
2019
Q3 | $34K | Hold |
200
| – | – | ﹤0.01% | 379 |
|
2019
Q2 | $37K | Hold |
200
| – | – | ﹤0.01% | 370 |
|
2019
Q1 | $37K | Buy |
+200
| New | +$37K | ﹤0.01% | 373 |
|
2017
Q4 | – | Sell |
-61,479
| Closed | -$9.35M | – | 1068 |
|
2017
Q3 | $9.35M | Buy |
61,479
+4,546
| +8% | +$691K | 0.03% | 479 |
|
2017
Q2 | $7.34M | Sell |
56,933
-9,398
| -14% | -$1.21M | 0.02% | 596 |
|
2017
Q1 | $7.25M | Sell |
66,331
-8,078
| -11% | -$883K | 0.02% | 647 |
|
2016
Q4 | $5.48M | Buy |
74,409
+13,591
| +22% | +$1M | 0.02% | 667 |
|
2016
Q3 | $5.3M | Buy |
60,818
+351
| +0.6% | +$30.6K | 0.02% | 664 |
|
2016
Q2 | $5.2M | Buy |
60,467
+19,919
| +49% | +$1.71M | 0.02% | 612 |
|
2016
Q1 | $3.22M | Buy |
40,548
+857
| +2% | +$68.1K | 0.02% | 667 |
|
2015
Q4 | $4.99M | Sell |
39,691
-9,700
| -20% | -$1.22M | 0.02% | 560 |
|
2015
Q3 | $5.14M | Sell |
49,391
-21,366
| -30% | -$2.22M | 0.03% | 552 |
|
2015
Q2 | $8.74M | Buy |
70,757
+25,805
| +57% | +$3.19M | 0.04% | 441 |
|
2015
Q1 | $5.3M | Sell |
44,952
-1,724
| -4% | -$203K | 0.02% | 597 |
|
2014
Q4 | $5.63M | Sell |
46,676
-970
| -2% | -$117K | 0.02% | 593 |
|
2014
Q3 | $5.35M | Sell |
47,646
-2,476
| -5% | -$278K | 0.02% | 588 |
|
2014
Q2 | $4.75M | Sell |
50,122
-7,431
| -13% | -$703K | 0.02% | 638 |
|
2014
Q1 | $4.07M | Buy |
57,553
+2,486
| +5% | +$176K | 0.02% | 667 |
|
2013
Q4 | $4.09M | Buy |
55,067
+4,510
| +9% | +$335K | 0.02% | 659 |
|
2013
Q3 | $3.83M | Buy |
+50,557
| New | +$3.83M | 0.02% | 655 |
|